IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 180 filers reported holding IMPAX LABORATORIES INC in Q1 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $40,001,000 | +64.1% | 2,056,607 | +40.5% | 0.29% | +63.5% |
| Q4 2017 | $24,380,000 | -25.9% | 1,464,248 | -9.6% | 0.18% | -24.9% |
| Q3 2017 | $32,897,000 | +28.8% | 1,620,548 | +2.2% | 0.24% | +27.4% |
| Q2 2017 | $25,532,000 | +82.2% | 1,585,828 | +43.2% | 0.19% | +78.8% |
| Q1 2017 | $14,012,000 | – | 1,107,660 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |